Struthers Richard Scott 13D/13G Filings for Crinetics Pharmaceuticals, Inc. (CRNX)

Struthers Richard Scott 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-10
4:30 pm
Purchase
2021-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
Struthers Richard Scott 1,978,334
4.200%
274,339increase
(+16.10%)
Filing
2021-02-05
4:21 pm
Purchase
2020-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
Struthers Richard Scott 1,703,995
5.100%
200,841increase
(+13.36%)
Filing